Press Releases

Press Releases

June 21, 2018
Surface Oncology Recognized as one of the “Best Places to Work” by Boston Business Journal
June 12, 2018
Surface Oncology Announces Initiation of Phase I Clinical Trial of SRF373 / NZV930
June 11, 2018
Surface Oncology to be Added to the Russell 3000 Index and Russell 2000 Index
June 8, 2018
Surface Oncology to Present at Goldman Sachs 39th Annual Global Healthcare Conference
May 29, 2018
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2018
May 15, 2018
Surface Oncology to Present at 2018 UBS Global Healthcare Conference
April 23, 2018
Surface Oncology Announces Closing of $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement
April 18, 2018
Surface Oncology Announces $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement
March 20, 2018
Surface Oncology Announces First Patient Dosed in Phase 1 Clinical Trial of SRF231
February 22, 2018
Surface Oncology Expands Board Of Directors
Displaying 1 - 10 of 11